The Safety and Efficacy of ECMO in the Management of Patients With Respiratory Failure

Inclusion criteria

• Age ≥18, male or female;
• Patients with respiratory failure and high Paco2, PH < 7.35；
• Researchers believe that this product is beneficial for patients undergoing treatment, such as patients with invasive ventilator weaning difficulty, large airway obstruction, etc；
• Patients or guardians provided written informed consent voluntarily.

Exclusion criteria

• Oxygenation index <80mmHg;
• Intracranial hemorrhage or severe irreversible brain injury;
• Thrombocytopenia;
• Patients with malignant tumors (expected survival time <1 year);
• patients unable to receive systemic anticoagulation;
• Obesity: BMI>40kg/m2;
• Those with a history of mental illness who were unable to cooperate in completing the trial;
• During pregnancy and lactation;
• Patients with allergic or severe allergic constitution to the test equipment;
• Participated in other interventional device clinical trials within 3 months before this trial
• Those who were deemed unsuitable to participate in the trial by the investigators.